Transfection Reagents and Equipment Market Report by Product (Reagents, Equipment), Technology (Biochemical Based Transfection, Physical Transfection, Viral-Vector Based Transfection), Application (Biomedical Research, Protein Production, Therapeutic Deli

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,999	138 Pages	IMARC Services Pvt. Ltd.	April, 2024	IMRC18711936

Best Price Guarantee
Price	from $2,999
Length	138 Pages
Publisher	IMARC Services Pvt. Ltd.
Published Date	April, 2024
SKU	IMRC18711936

Transfection Reagents and Equipment Market Report by Product (Reagents, Equipment), Technology (Biochemical Based Transfection, Physical Transfection, Viral-Vector Based Transfection), Application (Biomedical Research, Protein Production, Therapeutic Delivery), End User (Pharmaceutical and Biotechnology Companies, Academics and Research Institutes), and Region 2024-2032

The global transfection reagents and equipment market size reached US$ 971.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,766.9 Million by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.

Transfection reagents and equipment help modulate gene expression in eukaryotic cells in vitro and in vivo. They allow researchers to generate stable cell lines and introduce deoxyribonucleic acid (DNA) plasmids possessing gene inserts for expression and small interfering RNA (siRNA). They are currently being used as viable analytical tools for protein synthesis, cell growth and development, and facilitating the study of genetic functions. Besides this, as they provide cost-effective and rapid production of recombinant human therapeutic proteins in sufficient quantities, transfection reagents and equipment are also gaining traction in producing r-proteins, antibodies, and viral vectors for vaccines.

Transfection Reagents and Equipment Market Trends:
Due to the outbreak of coronavirus disease (COVID-19) globally, governing agencies of numerous countries are focusing on accelerating the vaccination drive. However, due to the emergence of new variants, the protection and immunity that these vaccines provide are short-lived. As a result, there is a rise in the need of transfection reagents and equipment to develop innovative strategies or alternatively repurpose existing treatments to fight against virus infection. Apart from this, rapid detection of new cancer variants, coupled with the escalating demand for precision medicine and high-quality oncology care, are driving the adoption of transfection reagents and equipment in cancer research and drug development. Moreover, the emerging use of gene therapies to treat rare diseases caused by genetic problems is impelling the market growth. Furthermore, due to the growing number of fatal road accidents across the globe, there is a significant rise in the demand for tissue engineering to develop functional substitutes for damaged tissues. This, in turn, is propelling the market growth. Besides this, recent advancements in transfection technologies, along with increasing investments in pharmaceutical and biotechnology sectors, are anticipated to drive the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global transfection reagents and equipment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

Reagents
Equipment

Breakup by Technology:

Biochemical Based Transfection
Physical Transfection
Viral-Vector Based Transfection

Breakup by Application:

Biomedical Research
Protein Production
Therapeutic Delivery

Breakup by End User:

Pharmaceutical and Biotechnology Companies
Academics and Research Institutes

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bio-Rad Laboratories Inc., Lonza Group AG, MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PerkinElmer Inc., Polyplus-transfection SA, Promega Corporation, PromoCell GmbH, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. What was the size of the global transfection reagents and equipment market in 2023?
2. What is the expected growth rate of the global transfection reagents and equipment market during 2024-2032?
3. What are the key factors driving the global transfection reagents and equipment market?
4. What has been the impact of COVID-19 on the global transfection reagents and equipment market?
5. What is the breakup of the global transfection reagents and equipment market based on the product?
6. What is the breakup of the global transfection reagents and equipment market based on the technology?
7. What is the breakup of the global transfection reagents and equipment market based on the application?
8. What is the breakup of the global transfection reagents and equipment market based on the end user?
9. What are the key regions in the global transfection reagents and equipment market?
10. Who are the key players/companies in the global transfection reagents and equipment market?

1 Preface
2 Scope and Methodology: 2.1 Objectives of the Study; 2.2 Stakeholders; 2.3 Data Sources; 2.3.1 Primary Sources; 2.3.2 Secondary Sources; 2.4 Market Estimation; 2.4.1 Bottom-Up Approach; 2.4.2 Top-Down Approach; 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction: 4.1 Overview; 4.2 Key Industry Trends
5 Global Transfection Reagents and Equipment Market: 5.1 Market Overview; 5.2 Market Performance; 5.3 Impact of COVID-19; 5.4 Market Forecast
6 Market Breakup by Product: 6.1 Reagents; 6.1.1 Market Trends; 6.1.2 Market Forecast; 6.2 Equipment; 6.2.1 Market Trends; 6.2.2 Market Forecast
7 Market Breakup by Technology: 7.1 Biochemical Based Transfection; 7.1.1 Market Trends; 7.1.2 Market Forecast; 7.2 Physical Transfection; 7.2.1 Market Trends; 7.2.2 Market Forecast; 7.3 Viral-Vector Based Transfection; 7.3.1 Market Trends; 7.3.2 Market Forecast
8 Market Breakup by Application: 8.1 Biomedical Research; 8.1.1 Market Trends; 8.1.2 Market Forecast; 8.2 Protein Production; 8.2.1 Market Trends; 8.2.2 Market Forecast; 8.3 Therapeutic Delivery; 8.3.1 Market Trends; 8.3.2 Market Forecast
9 Market Breakup by End User: 9.1 Pharmaceutical and Biotechnology Companies; 9.1.1 Market Trends; 9.1.2 Market Forecast; 9.2 Academics and Research Institutes; 9.2.1 Market Trends; 9.2.2 Market Forecast
10 Market Breakup by Region: 10.1 North America; 10.1.1 United States; 10.1.1.1 Market Trends; 10.1.1.2 Market Forecast; 10.1.2 Canada; 10.1.2.1 Market Trends; 10.1.2.2 Market Forecast; 10.2 Asia-Pacific; 10.2.1 China; 10.2.1.1 Market Trends; 10.2.1.2 Market Forecast; 10.2.2 Japan; 10.2.2.1 Market Trends; 10.2.2.2 Market Forecast; 10.2.3 India; 10.2.3.1 Market Trends; 10.2.3.2 Market Forecast; 10.2.4 South Korea; 10.2.4.1 Market Trends; 10.2.4.2 Market Forecast; 10.2.5 Australia; 10.2.5.1 Market Trends; 10.2.5.2 Market Forecast; 10.2.6 Indonesia; 10.2.6.1 Market Trends; 10.2.6.2 Market Forecast; 10.2.7 Others; 10.2.7.1 Market Trends; 10.2.7.2 Market Forecast; 10.3 Europe; 10.3.1 Germany; 10.3.1.1 Market Trends; 10.3.1.2 Market Forecast; 10.3.2 France; 10.3.2.1 Market Trends; 10.3.2.2 Market Forecast; 10.3.3 United Kingdom; 10.3.3.1 Market Trends; 10.3.3.2 Market Forecast; 10.3.4 Italy; 10.3.4.1 Market Trends; 10.3.4.2 Market Forecast; 10.3.5 Spain; 10.3.5.1 Market Trends; 10.3.5.2 Market Forecast; 10.3.6 Russia; 10.3.6.1 Market Trends; 10.3.6.2 Market Forecast; 10.3.7 Others; 10.3.7.1 Market Trends; 10.3.7.2 Market Forecast; 10.4 Latin America; 10.4.1 Brazil; 10.4.1.1 Market Trends; 10.4.1.2 Market Forecast; 10.4.2 Mexico; 10.4.2.1 Market Trends; 10.4.2.2 Market Forecast; 10.4.3 Others; 10.4.3.1 Market Trends; 10.4.3.2 Market Forecast; 10.5 Middle East and Africa; 10.5.1 Market Trends; 10.5.2 Market Breakup by Country; 10.5.3 Market Forecast
11 SWOT Analysis: 11.1 Overview; 11.2 Strengths; 11.3 Weaknesses; 11.4 Opportunities; 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis: 13.1 Overview; 13.2 Bargaining Power of Buyers; 13.3 Bargaining Power of Suppliers; 13.4 Degree of Competition; 13.5 Threat of New Entrants; 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape: 15.1 Market Structure; 15.2 Key Players; 15.3 Profiles of Key Players; 15.3.1 Bio-Rad Laboratories Inc.; 15.3.1.1 Company Overview; 15.3.1.2 Product Portfolio; 15.3.1.3 Financials; 15.3.1.4 SWOT Analysis; 15.3.2 Lonza Group AG; 15.3.2.1 Company Overview; 15.3.2.2 Product Portfolio; 15.3.2.3 Financials; 15.3.2.4 SWOT Analysis; 15.3.3 MaxCyte Inc.; 15.3.3.1 Company Overview; 15.3.3.2 Product Portfolio; 15.3.3.3 Financials; 15.3.4 Merck KGaA; 15.3.4.1 Company Overview; 15.3.4.2 Product Portfolio; 15.3.4.3 Financials; 15.3.4.4 SWOT Analysis; 15.3.5 Mirus Bio LLC; 15.3.5.1 Company Overview; 15.3.5.2 Product Portfolio; 15.3.6 OriGene Technologies Inc.; 15.3.6.1 Company Overview; 15.3.6.2 Product Portfolio; 15.3.7 PerkinElmer Inc.; 15.3.7.1 Company Overview; 15.3.7.2 Product Portfolio; 15.3.7.3 Financials; 15.3.7.4 SWOT Analysis; 15.3.8 Polyplus-transfection SA; 15.3.8.1 Company Overview; 15.3.8.2 Product Portfolio; 15.3.9 Promega Corporation; 15.3.9.1 Company Overview; 15.3.9.2 Product Portfolio; 15.3.10 PromoCell GmbH; 15.3.10.1 Company Overview; 15.3.10.2 Product Portfolio; 15.3.11 Qiagen N.V.; 15.3.11.1 Company Overview; 15.3.11.2 Product Portfolio; 15.3.11.3 Financials; 15.3.11.4 SWOT Analysis; 15.3.12 Thermo Fisher Scientific Inc.; 15.3.12.1 Company Overview; 15.3.12.2 Product Portfolio; 15.3.12.3 Financials; 15.3.12.4 SWOT Analysis

Transfection Technologies Market – By Product (Kits and Reagents, Equipment), Method (Physical Transfection, Biochemical-based Transfection), Application (Therapeutic Delivery, Biomedical Research), End-use – Global Forecast (2024 – 2032)

April, 2024 | Published by: Global Market Insights | USD $4,850
Transfection Technologies Market Size, Trends, Analysis, and Outlook By Product (Kits & Reagents, Equipment), By Method (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), By Application (Therapeutic Delivery, Biomedical Research, Protein Production, Cell Based microarrays), By End-User (Pharmaceutical and Biotechnology Companies, CROs & CDMOs, Academic and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032

April, 2024 | Published by: VPA Research | USD $3,980
Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection, Calcium Phosphate), Viral), Application (Biomedical Research, Therapeutic Delivery) - Global Forecast to 2028

February, 2024 | Published by: MarketsandMarkets | USD $4,950
Transfection Reagents & Equipment Market by Product (Equipment, Reagents), Method (Biochemical Methods, Physical Methods, Viral Methods), Application, End User - Global Forecast 2024-2030

June, 2024 | Published by: 360iResearch | USD $4,949
Transfection Technologies Market Report by Product Type (Reagent, Instrument, and Others), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), Transfection Method (Lipofection, Eletroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, and Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End-User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Region 2025-2033

February, 2025 | Published by: IMARC Services Pvt. Ltd. | USD $2,999
Europe Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)

July, 2024 | Published by: The Insight Partners | USD $3,450

PDF E-mail From Publisher:	$2,999
Five User License Fulfilled by Publisher:	$3,999
Global Site License Fulfilled by Publisher:	$4,999

Transfection Reagents and Equipment Market Report by Product (Reagents, Equipment), Technology (Biochemical Based Transfection, Physical Transfection, Viral-Vector Based Transfection), Application (Biomedical Research, Protein Production, Therapeutic Deli

Research Assistance

Other tasks

Transfection Reagents and Equipment Market Report by Product (Reagents, Equipment), Technology (Biochemical Based Transfection, Physical Transfection, Viral-Vector Based Transfection), Application (Biomedical Research, Protein Production, Therapeutic Deli

Transfection Technologies Market – By Product (Kits and Reagents, Equipment), Method (Physical Transfection, Biochemical-based Transfection), Application (Therapeutic Delivery, Biomedical Research), End-use – Global Forecast (2024 – 2032)

Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection, Calcium Phosphate), Viral), Application (Biomedical Research, Therapeutic Delivery) - Global Forecast to 2028

Transfection Reagents & Equipment Market by Product (Equipment, Reagents), Method (Biochemical Methods, Physical Methods, Viral Methods), Application, End User - Global Forecast 2024-2030

Research Assistance

Other tasks